Gait characteristics associated with the foot and ankle in inflammatory arthritis: a systematic review and meta‐analysis

Gait characteristics associated with the foot and ankle in inflammatory arthritis: a systematic review and meta‐analysis

Bibliographic Details
Main Authors:	Matthew Carroll, Priya Parmar, Nicola Dalbeth, Mark Boocock, Keith Rome
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	Journal of Foot and Ankle Research
Subjects:	Gait Rheumatoid arthritis Ankylosing spondylitis Psoriatic arthritis Gout
Online Access:	https://doi.org/10.1186/1757-1146-8-S2-P2

Similar Items

Nod-like receptors in inflammatory arthritis
by: Sahib Singh Madahar, et al.
Published: (2024-02-01)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
by: Takacs P, et al.
Published: (2019-01-01)

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
by: Joshua L. Lee, et al.
Published: (2018-08-01)

Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
by: Milena Iwaszko, et al.
Published: (2021-11-01)

Rheumatoid arthritis and spondyloarthritis prevalence in four European countries - a comparative study
by: Zlatković-Švenda Mirjana, et al.
Published: (2022-01-01)

Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis
by: Santhi Mantravadi, et al.
Published: (2020-09-01)

Inflammatory arthritis and eye diseases: a Mendelian randomization study
by: Xinlin Nie, et al.
Published: (2023-10-01)

Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients
by: Chen HH, et al.
Published: (2017-05-01)

The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis
by: I. Pantano, et al.
Published: (2023-03-01)

Comorbidities in inflammatory joint and spine diseases in XXI century
by: I Z Gaydukova, et al.
Published: (2018-12-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015-03-01)

Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
by: Vandana Bhushan, et al.
Published: (2021-09-01)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
by: Krzysztof Bonek, et al.
Published: (2022-04-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
by: Viola Sacchi, et al.
Published: (2010-06-01)

Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies
by: Katarzyna Bogunia-Kubik, et al.
Published: (2021-07-01)

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
by: Philip Brenner, et al.
Published: (2020-02-01)

The effectiveness and safety of lifestyle medicine and integrative therapies in inflammatory arthritis: an umbrella review using a hierarchical evidence gathering approach
by: Joshua Lin, et al.
Published: (2024-03-01)

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line
by: Svedbom A, et al.
Published: (2017-01-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
by: M. Elaine Husni, et al.
Published: (2022-03-01)

Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion
by: Jozélio Freire de Carvalho, et al.
Published: (2018-08-01)

Characteristics of patients with psoriatic arthritis in Korea: focusing on axial involvement
by: Hanna Park, et al.
Published: (2024-01-01)

A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study
by: Christian Dejaco, et al.
Published: (2022-06-01)

Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases
by: Laura Cometi, et al.
Published: (2020-05-01)

The impact of SARS-CoV-2 infection and vaccination on inflammatory arthritis: a cohort study
by: Giovanni Striani, et al.
Published: (2023-07-01)

Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study
by: Muhammad Haroon, et al.
Published: (2018-04-01)

Assessment of foot and ankle muscle strength using hand held dynamometry in patients with established rheumatoid arthritis
by: Matthew Carroll, et al.
Published: (2013-01-01)

Coexistence of rheumatoid arthritis and ankylosing spondylitis
by: Tacjana Anna Barczyńska, et al.
Published: (2015-12-01)

Platelet indices in patients with chronic inflammatory arthritis: a systematic review and meta-analysis
by: Zhongwei Zhou, et al.
Published: (2020-10-01)

Short-term Efficacy and Safety of Secukinumab in Pakistani Patients with Ankylosing Spondylitis and Psoriatic Arthritis
by: Sumera Ghani, et al.
Published: (2023-06-01)

Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project
by: Jesús A. Valero-Jaimes, et al.
Published: (2021-01-01)

Newly diagnosed seropositive rheumatoid arthritis in a 52-year-old man superimposed on long-standing ankylosing spondylitis during secukinumab treatment
by: Jaroslaw Nowakowski, et al.
Published: (2023-10-01)

The association of relapsing polychondritis and spondylarthritis – three case reports
by: Eleonora Alina Dragomir-Lica, et al.
Published: (2023-09-01)

Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study
by: Deepak R. Jadon, et al.
Published: (2017-09-01)

IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients
by: Milena Iwaszko, et al.
Published: (2021-06-01)

The assessment of inflammatory and structural lesions of the Achilles tendon by ultrasound imaging in inflammatory arthritis: a systematic review and meta‐analysis
by: Matthew Carroll, et al.
Published: (2015-01-01)

TEMPOROMANDIBULAR JOINT INVOLVEMENT IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS: A CROSS-SECTIONAL STUDY
by: Cristina Iordache, et al.
Published: (2018-01-01)

Psoriasis, inflammatory bowel disease, and uveitis as paradoxical adverse effects induced by TNF inhibitors in patients with immune-inflammatory rheumatic conditions
by: Damiana Margineanu, et al.
Published: (2022-06-01)

Frequency of inflammatory back pain and sacroiliitis in Egyptian patients with rheumatoid arthritis
by: N.M.M. Osman, et al.
Published: (2019-09-01)

Risk of Adverse Events After Anti-TNF Treatment for Inflammatory Rheumatological Disease. A Meta-Analysis
by: Ju Li, et al.
Published: (2021-11-01)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
by: Lubrano E, et al.
Published: (2016-10-01)